The board of directors at Cygnal Therapeutics has a history of experience in the pharmaceutical industry, with a focus on biochemistry and engineering. The board members have also been involved with startups in the past, co-founding and chairing several companies. They hold degrees from Dartmouth College, McGill University, and the Massachusetts Institute of Technology.
View all